This page shows the latest Flatiron news and features for those working in and with pharma, biotech and healthcare.
Flatiron's Zach Weinberg. “In order for the entire industry to benefit from RWE, we must ensure that our datasets are comprehensive and of the highest-quality. ... Working with the FDA enables Flatiron to both learn from their leadership and continue
The news is eye-catching as it is the first after Roche completed its $1.9bn acquisition of Flatiron last month. ... Roche and Flatiron had stipulated that the buyout would not see Flatiron turning away new pharma partnerships.
Two successes and two failures provide interesting contrasts. The first good news is Flatiron’s acquisition by Roche, which reveals how using real-time big data is transforming oncology.
Data provides a wealth of RWE opportunities. Swiss pharma group Roche has beefed up its big data capabilities with a deal to buy Flatiron Health, which focuses on cancer data and ... Software developed by Flatiron - which is backed by Google parent
More from news
Approximately 2 fully matching, plus 2 partially matching documents found.
At. the same time, we are seeing companies like Flatiron Health using real-world data to learn from patients who are not in clinical trials.
Maybe Roche’s $1.7bn acquisition of Flatiron Health is the first foray into such an exploration of healthcare data.
EHR provider Flatiron Health.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...